MedPath

Effects of exercise on nonalcoholic fatty liver disease

Not Applicable
Conditions
onalcoholic fatty liver disease (NAFLD).
Nonalcoholic fatty liver disease (NAFLD)
Registration Number
IRCT2017011821258N2
Lead Sponsor
Islamic Azad University of Boroujerd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
16
Inclusion Criteria

1. non-alcoholic fatty liver disease; 2. males; 3. having the age range of 45-30 years old.
Exclusion criteria:
1. under the age of 30 years ; 2. age over 45 years old; 3. patients with cardiovascular disease; 4. patients with high blood pressure; 5. patients who have studied interoperability; 6. patients with musculoskeletal disorders; 7. people with Medical ban to participate in sports activities; 8. alcohol consumption.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Alanine Aminotransferase Enzyme (ALT). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Blood Aspartate Aminotransferase Enzyme (AST). Timepoint: Baseline and final (6th week). Method of measurement: Blood samples test.;Liver fats. Timepoint: Baseline and final (6th week). Method of measurement: Liver ultrasound.;Body weight. Timepoint: Baseline and final (6th week). Method of measurement: Digital balance.;Body mass index. Timepoint: Baseline and final (6th week). Method of measurement: Weight (kg) divided by square of height (m).;Maximum oxygen uptake. Timepoint: Baseline and final (6th week). Method of measurement: Rockport Fitness Walking Test.;Waist-to-hip ratio (WHR). Timepoint: Baseline and final (6th week). Method of measurement: Waist circumference divided by hip circumference.;Body fat percent. Timepoint: baseline and final (6th week). Method of measurement: Measurement of skin fold thickness.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath